YahooOctober 22, 2026 at 2:36 PM NY4 Days Ago
Moderna Stock Plunges as Apparent Leak Reveals Phase 3 Melanoma Vaccine Data
Key TakeawaysModerna Inc. (NASDAQ:MRNA) sank as much as roughly 25% intraday after apparent Phase 3 results for its personalized melanoma vaccine surfaced online ahead of an embargoed medical-conference presentation.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo
